ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve

NCT ID: NCT06491758

Last Updated: 2025-02-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-02

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find out if we can gain access to the vagus nerve which is largely an internal nerve that controls stomach function. We hope to gain access to the internal vagus nerve by electrically stimulating the nerve around the external ear. If we can do this then we hope that this will help our treatment of patients with nausea and vomiting and disordered stomach function

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will undergo transcutaneous stimulation of the auricular branch of the vagus nerve and also undergo blood draw before, after stimulation and later a third draw after a period of no stimulation. Healthy subjects will also undergo vagal maneuver using the Multi Array Electrodes (MEA). Gastroparetic subjects will also undergo vagal maneuver using either the regular EKG electrodes or the MEA electrodes.

Subjects will also complete health history questionnaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroparesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Subjects

Subjects who have no gastric symptoms or conditions

Group Type EXPERIMENTAL

ML1101 Stimulus Isolator

Intervention Type DEVICE

Electrical stimulation electrodes will be placed on the ear with the intensity of the current being increased by 10 percent every 60 seconds, the subject will grade the intensity of the current on a scale of 0-10. Increasing of the current will occur until the subject reports a comfortable level. Once the target level has been achieved the stimulation will be delivered for 2 minutes.

Vagal Maneuver

Intervention Type PROCEDURE

Subjects will undergo the following procedures to stimulate the vagus nerve.

* Cough: 6 to 8 forceful coughs
* Cold stimulus: a washcloth soaked in ice water will be placed on the face for 10 seconds.
* Carotid massage
* Gagging: a tongue depressor will be inserted for 10 seconds into the mouth touching the back of the mouth.
* Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing.
* Eating: Subjects will be asked to drink water ( 8oz or 1 cup) or/ and Ensure Original ( 8 oz or 1 cup) that has 220 calories after fasting overnight to see that effect on vagal activity during eating.

Gastroparesis Subjects

Subjects with a confirmed diagnosis of gastroparesis.

Group Type EXPERIMENTAL

ML1101 Stimulus Isolator

Intervention Type DEVICE

Electrical stimulation electrodes will be placed on the ear with the intensity of the current being increased by 10 percent every 60 seconds, the subject will grade the intensity of the current on a scale of 0-10. Increasing of the current will occur until the subject reports a comfortable level. Once the target level has been achieved the stimulation will be delivered for 2 minutes.

Vagal Maneuver

Intervention Type PROCEDURE

Subjects will undergo the following procedures to stimulate the vagus nerve.

* Cough: 6 to 8 forceful coughs
* Cold stimulus: a washcloth soaked in ice water will be placed on the face for 10 seconds.
* Carotid massage
* Gagging: a tongue depressor will be inserted for 10 seconds into the mouth touching the back of the mouth.
* Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing.
* Eating: Subjects will be asked to drink water ( 8oz or 1 cup) or/ and Ensure Original ( 8 oz or 1 cup) that has 220 calories after fasting overnight to see that effect on vagal activity during eating.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ML1101 Stimulus Isolator

Electrical stimulation electrodes will be placed on the ear with the intensity of the current being increased by 10 percent every 60 seconds, the subject will grade the intensity of the current on a scale of 0-10. Increasing of the current will occur until the subject reports a comfortable level. Once the target level has been achieved the stimulation will be delivered for 2 minutes.

Intervention Type DEVICE

Vagal Maneuver

Subjects will undergo the following procedures to stimulate the vagus nerve.

* Cough: 6 to 8 forceful coughs
* Cold stimulus: a washcloth soaked in ice water will be placed on the face for 10 seconds.
* Carotid massage
* Gagging: a tongue depressor will be inserted for 10 seconds into the mouth touching the back of the mouth.
* Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing.
* Eating: Subjects will be asked to drink water ( 8oz or 1 cup) or/ and Ensure Original ( 8 oz or 1 cup) that has 220 calories after fasting overnight to see that effect on vagal activity during eating.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers with no gastric symptoms or conditions (except due to COVID 19)
* Aged 18-80 years
* Willing to have electrodes placed in the external ear (ABVN arm)
* Willing to perform vagal activity maneuver (Vagal arm)
* Willing to have 1 tablespoon (15 ml) of blood drawn at 3 time points


* Gastroparesis subjects with a confirmed diagnosis of gastroparesis from a GI physician
* Have a formal diagnosis of gastroparesis or are seeing the GI physician for symptoms related to gastroparesis
* Aged 18-80 years
* Willing to have electrodes placed in the external ear (ABVN arm)
* Willing to perform vagal activity maneuver (Vagal arm)
* Willing to have 1 tablespoon (15 ml) of blood drawn at 3 time points

Exclusion Criteria

* Unable to provide consent
* Pregnant females
* Prisoners
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indiana University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas V. Nowak

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas V Nowak, MD

Role: PRINCIPAL_INVESTIGATOR

Indiana University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Indiana University

Indianapolis, Indiana, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maureen Schilling, BS

Role: CONTACT

3172782064

Lainna Cohen, MSW

Role: CONTACT

3172780621

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maureen Schilling, BS

Role: primary

317-278-2064

Lainna Cohen, MSW

Role: backup

3172780621

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2006075899- A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TVNS and Upper GI Motility
NCT06700200 NOT_YET_RECRUITING NA
Mapping Auricular Vagus Nerve Circuitry
NCT00200889 RECRUITING EARLY_PHASE1
Neural Correlates of tVNS
NCT04810234 UNKNOWN
Noninvasive Vagal Nerve Stimulation
NCT06816004 RECRUITING NA